Drugs / FLU
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06384976 Background | Sep 2024 → Apr 2027 expected | primary progressive multiple sclerosis, secondary progressive multiple sclerosis | Kyverna Therapeutics | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLU | “CYC/FLU” NCT06384976 ↗ |